| Recurrent Fusion of TMPRSS2 and ETS Transcription Factor Genes in Prostate Cancer SA Tomlins, DR Rhodes, S Perner, SM Dhanasekaran, R Mehra, XW Sun, ... science 310 (5748), 644-648, 2005 | 4898 | 2005 |
| FLICE, a novel FADD-homologous ICE/CED-3–like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex M Muzio, AM Chinnaiyan, FC Kischkel, K O'Rourke, A Shevchenko, J Ni, ... Cell 85 (6), 817-827, 1996 | 3994 | 1996 |
| Integrative clinical genomics of advanced prostate cancer D Robinson, EM Van Allen, YM Wu, N Schultz, RJ Lonigro, JM Mosquera, ... Cell 161 (5), 1215-1228, 2015 | 3962 | 2015 |
| ONCOMINE: a cancer microarray database and integrated data-mining platform DR Rhodes, J Yu, K Shanker, N Deshpande, R Varambally, D Ghosh, ... Neoplasia 6 (1), 1-6, 2004 | 3934 | 2004 |
| FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis AM Chinnaiyan, K O'Rourke, M Tewari, VM Dixit Cell 81 (4), 505-512, 1995 | 3479 | 1995 |
| The polycomb group protein EZH2 is involved in progression of prostate cancer S Varambally, SM Dhanasekaran, M Zhou, TR Barrette, C Kumar-Sinha, ... Nature 419 (6907), 624-629, 2002 | 3359 | 2002 |
| Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control B Zhao, X Wei, W Li, RS Udan, Q Yang, J Kim, J Xie, T Ikenoue, J Yu, L Li, ... Genes & development 21 (21), 2747-2761, 2007 | 3313 | 2007 |
| The landscape of long noncoding RNAs in the human transcriptome MK Iyer, YS Niknafs, R Malik, U Singhal, A Sahu, Y Hosono, TR Barrette, ... Nature genetics 47 (3), 199-208, 2015 | 2825 | 2015 |
| The mutational landscape of lethal castration-resistant prostate cancer CS Grasso, YM Wu, DR Robinson, X Cao, SM Dhanasekaran, AP Khan, ... Nature 487 (7406), 239-243, 2012 | 2818 | 2012 |
| TEAD mediates YAP-dependent gene induction and growth control B Zhao, X Ye, J Yu, L Li, W Li, S Li, J Yu, JD Lin, CY Wang, ... Genes & development 22 (14), 1962-1971, 2008 | 2605 | 2008 |
| Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression A Sreekumar, LM Poisson, TM Rajendiran, AP Khan, Q Cao, J Yu, ... Nature 457 (7231), 910-914, 2009 | 2577 | 2009 |
| The receptor for the cytotoxic ligand TRAIL G Pan, K O'Rourke, AM Chinnaiyan, R Gentz, R Ebner, J Ni, VM Dixit Science 276 (5309), 111-113, 1997 | 2457 | 1997 |
| DNA-repair defects and olaparib in metastatic prostate cancer J Mateo, S Carreira, S Sandhu, S Miranda, H Mossop, R Perez-Lopez, ... New England Journal of Medicine 373 (18), 1697-1708, 2015 | 2405 | 2015 |
| Oncomine 3.0: genes, pathways, and networks in a collection of 18,000 cancer gene expression profiles DR Rhodes, S Kalyana-Sundaram, V Mahavisno, R Varambally, J Yu, ... Neoplasia 9 (2), 166-180, 2007 | 2282 | 2007 |
| Delineation of prognostic biomarkers in prostate cancer SM Dhanasekaran, TR Barrette, D Ghosh, R Shah, S Varambally, ... Nature 412 (6849), 822-826, 2001 | 2154 | 2001 |
| CD8+ T cells regulate tumour ferroptosis during cancer immunotherapy W Wang, M Green, JE Choi, M Gijón, PD Kennedy, JK Johnson, P Liao, ... Nature 569 (7755), 270-274, 2019 | 2149 | 2019 |
| EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells CG Kleer, Q Cao, S Varambally, R Shen, I Ota, SA Tomlins, D Ghosh, ... Proceedings of the national academy of sciences 100 (20), 11606-11611, 2003 | 2039 | 2003 |
| The emergence of lncRNAs in cancer biology JR Prensner, AM Chinnaiyan Cancer discovery 1 (5), 391-407, 2011 | 1936 | 2011 |
| Inherited DNA-repair gene mutations in men with metastatic prostate cancer CC Pritchard, J Mateo, MF Walsh, N De Sarkar, W Abida, H Beltran, ... New England Journal of Medicine 375 (5), 443-453, 2016 | 1754 | 2016 |
| The landscape of circular RNA in cancer JN Vo, M Cieslik, Y Zhang, S Shukla, L Xiao, Y Zhang, YM Wu, ... Cell 176 (4), 869-881. e13, 2019 | 1387 | 2019 |
